Whole Genome Sequencing

CARLSBAD, Calif., June 11, 2026 Arima Genomics, a cancer diagnostics company focused on integrating DNA sequence and genome structure...

IRVING, Texas – May 4, 2026 Caris Life Sciences has secured MolDX approval for its flagship Caris ChromoSeq™ assay,...

Chicago, Illinois, U.S. | April 15, 2026 Tempus AI, Inc., in collaboration with Predicta Biosciences, has announced the expansion...

IRVING, Texas, USA, March 31, 2026 Caris Life Sciences has announced final results from the Achieve 1 study, demonstrating...

IRVING, Texas, February 26, 2026 Caris Life Sciences® (NASDAQ: CAI) announced an interim readout from its Achieve 1 clinical...

Dateline – Silver Spring, MD, September 18, 2025 – The U.S. Food and Drug Administration (FDA), in coordination with...